Entheon Biomedical Corp. (CSE:ENBI.X)
Canada · Delayed Price · Currency is CAD 0.0600
0.00 (0.00%)
At close: Jul 21, 2026
Entheon Biomedical Company Description
Entheon Biomedical Corp. operates as a biotechnology research and development company. It develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
Entheon Biomedical Corp.
| Country | Canada |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 1 |
| CEO | Timothy Ko |
Contact Details
Address: 999 West Broadway Vancouver, BC V5Z 1K5 Canada | |
| Phone | 604-562-3932 |
| Website | entheonbiomedical.com |
Stock Details
| Ticker Symbol | ENBI.X |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | December - November |
| Reporting Currency | CAD |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Timothy Ko | Chief Executive Officer |
| Soo-Whan Kim | Chief Financial Officer |